🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Primary trial objective in this single arm trial is to assess the safety an...
Status
Completed
Location
Department of Thoracic Oncology, Netherlands Cancer Instiute - Antoni van Leeuwenhoek Hospital
Start Date
2009-04
Trial ID
NCT00879866
Treatments Being Tested
This is a multicenter, open-label, Phase 1b/2 efficacy and safety study of ...
Status
Terminated
Location
Uniwersyteckie Centrum Kliniczne Klinika Onkoligii i Radioterapii
Start Date
2022-12-07
Trial ID
NCT04915404
Treatments Being Tested
The purpose of this study is to compare the efficacy and safety of venetocl...
Status
Completed
Location
Chinese PLA General Hospital
Start Date
2023-03-01
Trial ID
NCT06068621
The first testing of TargomiRs in the human setting: dose-finding studies i...
Status
Completed
Location
Concord Repatriation General Hospital
Start Date
2014-09
Trial ID
NCT02369198
Treatments Being Tested
The overarching goal of this study is to develop PET/MR techniques for the ...
Status
Active Not Recruiting
Location
NYU Langone Health
Start Date
2022-02-15
Trial ID
NCT05615415
Treatments Being Tested
Quisinostat besides its own efficacy, which can potentially lead to better ...
Status
Completed
Location
Russian Oncological Research Center n.a. N. N. Blokhin RAMS
Start Date
2013-08
Trial ID
NCT02728492
Treatments Being Tested
The objective of this study is to demonstrate the efficacy of Dysport for t...
Status
Completed
Location
Peking University First Hospital
Start Date
2015-04
Trial ID
NCT02450526
Treatments Being Tested
The purpose of the protocol is to demonstrate the safety and the efficacy o...
Status
Completed
Location
Centre Médical Saint-Jean
Start Date
2015-04
Trial ID
NCT02493946
Treatments Being Tested
The primary objective of the study is to compare sacituzumab tirumotecan co...
Status
Recruiting
Location
Mayo Clinic in Arizona - Phoenix ( Site 0147)
Start Date
2023-12-15
Trial ID
NCT06170788
Treatments Being Tested
SP942 is a non-interventional post-authorization safety study (PASS) to eva...
Status
Completed
Location
Multiple Locations
Start Date
2008-10
Trial ID
NCT00771927
Treatments Being Tested